Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity—reply to a rebuttal
Louis M. Aledort, Mount Sinai Medical Center, Hematology/Oncology, New York, NY, USA.
Tel.: +1 212 241 7971; fax: +1 212 987 3326; e-mail: firstname.lastname@example.org
No abstract is available for this article.